Search

Pacira Pharmaceuticals Inc-DE

Uždarymo kaina

SektoriusSveikatos priežiūra

25.41 2.71

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

24.44

Max

25.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1.7M

4.7M

Pardavimai

15M

192M

P/E

Sektoriaus vid.

71.029

57.366

Pelnas, tenkantis vienai akcijai

0.44

Pelno marža

2.418

Darbuotojai

825

EBITDA

-3.9M

26M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+12.81% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-68M

991M

Ankstesnė atidarymo kaina

22.7

Ankstesnė uždarymo kaina

25.41

Naujienos nuotaikos

By Acuity

51%

49%

293 / 340 reitingas Healthcare

Pacira Pharmaceuticals Inc-DE Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-21 19:56; UTC

Pacira Biosciences Inc. shares are higher during Friday's session, recovering from a midday dip amid positive sentiment in the broader market.

2026-08-20 20:06; UTC

Pacira Biosciences Inc shares are lower today, continuing a decline from Wednesday's close. The stock remains below its 20-day moving average.

2026-08-19 19:46; UTC

Pacira Biosciences Inc. shares are higher today, reflecting a broader market trend amid declining bond yields. The stock remains below its 20-day moving average.

2026-08-18 20:03; UTC

Shares of Pacira Biosciences are higher, reflecting broader market strength. The stock remains below its 20-day moving average and near the lower end of its trading range.

2026-08-17 19:26; UTC

News

Pacira Biosciences Inc shares are higher following Truist Securities' reinstatement of coverage with a Buy rating and a price target of $30.00.

2026-08-14 19:36; UTC

Pacira Biosciences Inc shares are lower, marking the seventh consecutive decline. Broader market sentiment is affected by a reported drop in retail sales for July.

2026-08-13 20:06; UTC

Pacira Biosciences Inc shares fell during Thursday's session, continuing a trend of declines and remaining below the 20-day moving average. No specific news was identified.

2026-08-12 20:01; UTC

Pacira Biosciences Inc's shares are lower today, continuing a downward trend with a cumulative return of -3.36% since Tuesday. No specific news was identified.

2026-08-11 19:16; UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a trend of three consecutive declines. The stock is trading below its 20-day moving average.

2026-08-10 19:36; UTC

Pacira Biosciences Inc is trading lower, continuing a decline since Friday. The stock remains below its 20-day moving average amid broader market volatility.

2026-08-07 20:02; UTC

Event

Pacira Biosciences shares are lower despite positive two-year Phase 1 trial results for PCRX-201, an investigational gene therapy for knee osteoarthritis.

2026-08-06 19:52; UTC

News
Event

Pacira Biosciences Inc. shares are higher following positive two-year results from its Phase 1 trial for PCRX-201, a gene therapy for knee osteoarthritis.

2026-08-05 20:03; UTC

News

Pacira Biosciences reported improved earnings but lowered its 2026 revenue guidance, contributing to a decline in shares since Tuesday's close.

2026-08-04 19:53; UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

2026-08-03 20:06; UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

2026-07-31 20:02; UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

2026-07-30 17:16; UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

2026-07-29 20:04; UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

2026-07-28 19:56; UTC

Event
News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

2026-07-27 18:51; UTC

Event
News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

2026-07-24 17:16; UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

2026-07-22 18:06; UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

2026-07-21 19:56; UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

2026-07-20 19:46; UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Akcijų palyginimas

Kainos pokytis

Pacira Pharmaceuticals Inc-DE Prognozė

Kainos tikslas

By TipRanks

12.81% į viršų

12 mėnesių prognozė

Vidutinis 28.8 USD  12.81%

Aukščiausias 38 USD

Žemiausias 23 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pacira Pharmaceuticals Inc-DE kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

3

Pirkti

2

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

293 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
help-icon Live chat